HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CAP1-6D

agonist peptide from a cytotoxic T-lymphocyte epitope of human carcinoembryonic antigen
Also Known As:
CAP1
Networked: 88 relevant articles (3 outcomes, 23 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kakurina, G V: 7 articles (06/2021 - 03/2016)
2. Kondakova, I V: 7 articles (06/2021 - 03/2016)
3. Kolegova, E S: 6 articles (06/2021 - 01/2018)
4. Wang, Changhui: 5 articles (01/2022 - 10/2013)
5. Tan, Min: 5 articles (08/2019 - 10/2013)
6. Xie, Shuanshuan: 4 articles (01/2022 - 04/2017)
7. Cheremisina, O V: 4 articles (06/2021 - 03/2016)
8. Zhou, Guo-Lei: 4 articles (05/2019 - 01/2016)
9. Hummler, Edith: 4 articles (12/2016 - 01/2011)
10. Li, Xuan: 3 articles (01/2022 - 10/2013)

Related Diseases

1. Neoplasms (Cancer)
2. Metabolic Syndrome (Dysmetabolic Syndrome X)
3. Invasive Candidiasis
4. Lung Neoplasms (Lung Cancer)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Proteins (Proteins, Gene)
2. Peptides (Polypeptides)
3. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
4. Antigens
5. celastrol
6. Adenylyl Cyclases (Adenylyl Cyclase)
7. Resistin
8. Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)
9. NF-kappa B (NF-kB)
10. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

Related Therapies and Procedures

1. Photochemotherapy (Photodynamic Therapy)
2. Therapeutics
3. Immunotherapy
4. Oral Administration